To investigate the efficacy and safety of Qishenyiqi in patients with microvascular angina pectoris. Long-term follow-up of 1 year will be performed to evaluate the effect of Qishenyiqi on coronary flow reserve and adverse cardiovascular events in patients with coronary microvascular disease.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
162
Qishenyiqi dripping pills, 1 bag once, three times a day, 12 months
Placebo, 1 bag once, three times a day, 12 months
Qianfoshan Hospital, Shandong University
Jinan, Shandong, China
ACTIVE_NOT_RECRUITINGQilu Hospital of Shandong University
Jinan, Shandong, China
RECRUITINGJinan Central Hospital Affiliated to Shandong First Medical University
Jinan, Shandong, China
RECRUITINGChanges of coronary flow reserve measured by three-dimensional echocardiography from baseline to 12 months after follow-up
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.